![]() |
|
OMERACT 8: International Consensus Conference on Outcome Measures in Rheumatology
ORGANIZING COMMITTEE
ACKNOWLEDGMENT Financial support was provided by the following pharmaceutical companies and their subsidiaries: Abbott Laboratories, USA; Actelion, USA; Alderbio, USA; Astellas, USA; Amgen, USA; Astra Zeneca, UK; Bristol-Myers Squibb, USA; Centocor, USA; Combinatorx, USA; Eli Lilly, USA; Cypress/Forest Laboratories Inc., USA; Genzyme, USA; GlaxoSmithKline, UK; Hoffman LaRoche, USA; Pierre Fabre, France; Merck & Co., USA; Novartis Pharma AG, Switzerland; Organon, The Netherlands; Pfizer, USA; Savient Pharmaceuticals Inc., USA; Targeted Genetics, USA; Wyeth Pharmaceuticals, USA. We thank the Dutch Rheumatism Foundation for sponsorship of patients to attend the OMERACT Conference. The Organizing and Scientific Advisory Committees wish to thank the Module leaders, Workshop leaders, Special Interest Group leaders, guest speakers; special thanks to Liz Lacasse, Jil Beardmore, Lara Maxwell, Leanne Idzerda, and Q2Q Communications.
|